Skip to main content
Clinical Trials/EUCTR2007-005232-81-NL
EUCTR2007-005232-81-NLActive, not recruitingNot Applicable

Wet-wrap treatment in children with atopic eczema using the wet-wrap method with diluted corticosteroids versus emollients - Wet-wrap study

Havenziekenhuis/ErasmusMC0 sites50 target enrollmentStarted: January 8, 2008Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • Age 6 months- 6 years at inclusion
  • Diagnosis of atopic eczema with an objective SCORAD = 40
  • Parent/legal guardian willing to comply with the protocol
  • Written, dated consent for subject to participate
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • Known pre-existing, serious underlying disease
  • (secondary) infected eczema:
  • oIn case of overt impetiginisation, wet wrapping should be delayed until 48-72 hours after commencing antibiotics and confirmation of appropriate treatment by skin swab results.
  • oEczema herpeticum is an absolute contraindication for the use of wet dressings.
  • Signs and symptoms of systemic infection (such as fever, defined as a temperature equivalent to a rectal temperature greater than 38.3ºC).
  • Problems in the hypothalamus-pituitary-adrenal axis (HPA)
  • Systemic corticosteroid therapy
  • Severe growth retardation

Investigators

Sponsor
Havenziekenhuis/ErasmusMC

Similar Trials